The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
It’s well understood that any mask reduces the transmission of viral particles but some are more effective than others.
Study shows that temperature changes have a smaller effect on transmission than policy interventions like lockdowns and social distancing.
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.
Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.
Though risk is lower, researchers debate whether people should be encouraged to wear masks outdoors or should efforts instead focus on reducing indoor transmission?
While numbers indicate that the risks of COVID-19 still outweigh potential vaccine side effects, the current pause in vaccine distribution demonstrate the system is working and the public is onboard.
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
The strength of immune responses after the first dose of COVID-19 vaccines could make or break this strategy and policy makers need to be able to adapt.